About this trial
The objective of this study is to evaluate the effectiveness of a modified continuous renal replacement therapy (CRRT) protocol in maintaining electrolyte balance in adult patients with acute kidney injury (AKI) admitted to the intensive care unit (ICU).
The study assesses whether the use of continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement under citrate anticoagulation reduces electrolyte losses and the need for electrolyte supplementation compared with standard dialytic CRRT.
Participants receiving standard CRRT will be compared with those treated with the modified protocol.
The duration of participation corresponds to the period during which CRRT is required. Data collection will cease once CRRT is discontinued.
Eligibility criteria
Qualifiers
Age ≥18 years
Admission to the intensive care unit (ICU)
Diagnosis of acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT)
Use of regional citrate anticoagulation during CRRT
Disqualifiers
Known allergy or intolerance to citrate
Contraindications to citrate anticoagulation (e.g., severe liver failure or severe metabolic disorders affecting citrate metabolism)
Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- continuous renal replacement therapy